Several risk scores have been designed for this purpose (eg, TIMI [Thrombolysis in Myocardial Infarction], GRACE [Global Registry of Acute Coronary Events], HEART [History, ECG, Age, Risk factors and ...

The TCTMD news team share their latest, from troponin spikes in exercise to GLP-1s in PAD, STEMI delays, and the legacy of ...

Women with a history of preeclampsia have a nearly 2-fold increased risk of myocardial infarction later in life. The women with (n=82,980) and without (n=1,883,116) a history of preeclampsia had mean ...

Background: A wrist-worn wearable device for acquiring limb and chest ECG leads (wECG) may constitute a promising approach to detection of acute myocardial infarction (AMI). However, it remains to be ...

Terkelsen et al imply that the guidelines have distorted the evidence, particularly with respect to acceptable delays in delivering percutaneous coronary intervention (PCI), in order to favour ...

The timely treatment of STEMI varies substantially at the hospital level, for both primary presentation and transfers, and worse outcomes were observed in patients when the first medical contact (FMC) ...

The 2012 European Society of Cardiology (ESC) ST-Elevation Myocardial Infarction (STEMI) guideline acknowledges that STEMI patients should receive reperfusion therapy as soon as possible, and that ...

On admission to the hospital, the patient was in Killip class 1 with blood pressure 180/90 mmHg and a heart rate of 70 beats/min. Repeated ECG revealed sinus rhythm and normalization of the ST segment ...

In a report released on June 4, Dennis Ding from Jefferies maintained a Buy rating on Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) with a price target of $80.00.